Breast cancer, ER/PR-negative breast cancers, hormonal control, microenvironment, progesterone metabolites, 5α-dihydroprogesterone, 3α-dihydroprogesterone, tumorigenesis, tumor promoter and suppressor hormones, biomarkers, normalcy